GENinCode UK Ltd. (GB:GENI) has released an update.
GENinCode Plc, a UK-based predictive genetics company, successfully held its Annual General Meeting with all resolutions approved. The company, which operates in the UK, Europe, and the US, specializes in genetic risk assessment for cardiovascular disease and ovarian cancer, offering advanced preventive care through its innovative technology.
For further insights into GB:GENI stock, check out TipRanks’ Stock Analysis page.
